Projects
Explore a selection of our current and past research projects.
Cellulitis antibiotic treatment duration (COAT)
Status: ActiveLead researchers: Nicholas Andrew FrancisCRAIN (Astex) - Non-staff budget
Status: ActiveLead researchers: Gareth Owen GriffithsCTU - CCTG- Crabb - A RANDOMIZED PHASE II TRIAL ASSESSING TRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
Status: ActiveLead researchers: Gareth Owen GriffithsOptimizing MATrix as remission induction treatment for newly diagnosed primary CNS Lymphoma – a randomized phase III trial (OPTIMATE trial)
Status: ActiveLead researchers: Gareth Owen GriffithsA DAVIES - A Phase 1b/11 combination of ACP-196 with Rituximiab, Cyclophosphamide, doxorubicin, Vincristine and Prenisolone (R-CHOP) for patients with Diffused B-cell Lymphoma (DLBCL) - "ACCEPT" - ACP-196 - ACERTA
Status: Not activeLead researchers: Gareth Owen GriffithsA multicentre randomised controlled trial (RCT) of a uro-oncology clinical nurse specialist (CNS) team delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flush and night sweat (HFNS) symptoms in men with prostate cancer
Status: Not activeLead researchers: Simon CrabbAGILE: CST 3 Nitazoxanide
Status: Not activeLead researchers: Gareth Owen GriffithsAn open, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (PolaRICE) with rituximab, ifosfamide, carboplatin and etoposide (RICE) alone as salvage-therapy in patients with diffuse la
Status: Not activeLead researchers: Andrew John DaviesDebbie Fenlon, Breast Cancer Now - MENOS4: A multicentre Randomised Controlled Trial (RCT) of a breast care nurse delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flushes in women with breast cancer
Status: Not activeEccles - CRUK - C1275/A19187 Prospective study of Outcomes in Sporadic versus Hereditary Breast Cancer
Status: Not activeLead researchers: Diana Margaret Eccles